Prediction of Fear of COVID-19 in Women with Fibromyalgia: A Study of Psychosocial Factors Associated with Pain

Authors

DOI:

https://doi.org/10.56294/saludcyt20241179

Keywords:

Fibromyalgia, Pain Catastrophizing, Fear Of COVID-19, Kinesiophobia, Impact Of Fibromyalgia, Pain

Abstract

Introduction: the COVID-19 pandemic generated a significant increase in anxiety and fear in the population, especially in those with chronic conditions such as fibromyalgia. Although there is no evidence that fibromyalgia is a predictor of hospitalization or mortality associated with COVID-19, the infection can worsen fibromyalgia symptoms.
Methods: this study focused on evaluating the ability of psychosocial pain factors, such as pain intensity, pain catastrophizing, impact of fibromyalgia, and kinesiophobia, to predict fear of COVID-19 in women with fibromyalgia. A quantitative, observational-analytical design was used, with a sample of 33 women diagnosed with fibromyalgia. Fear of COVID-19 was assessed through a questionnaire and scales were used to measure the predictor variables.
Results: it was found that pain catastrophizing was the most significant predictor variable of fear of COVID-19. The correlation between pain catastrophizing and fear of COVID-19 was moderate, and the multiple regression model that included this variable predicted fear of COVID-19 with an adjusted R2 of 0.248.
Conclusions: fear of COVID-19 in women with fibromyalgia is related to pain catastrophizing. This study suggests that pain catastrophizing may be an important factor as a predictor of fear in new studies associated with new outbreaks of this disease

References

1. Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int J Mol Sci. 2021;22(8):3891. http://dx.doi.org/10.3390/ijms22083891

2. Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37(9):1527-39. http://dx.doi.org/10.1007/s00296-017-3725-2

3. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8(1):27. http://dx.doi.org/10.1186/1471-2474-8-27

4. Jensen KB, Srinivasan P, Spaeth R, Tan Y, Kosek E, Petzke F, et al. Overlapping Structural and Functional Brain Changes in Patients With Long‐Term Exposure to Fibromyalgia Pain. Arthritis Rheum. 2013;65(12):3293-303. http://dx.doi.org/10.1002/art.38170

5. Clauw DJ. Fibromyalgia: A Clinical Review. JAMA. 2014;311(15):1547. http://dx.doi.org/10.1001/jama.2014.3266

6. Albrecht DS, MacKie PJ, Kareken DA, Hutchins GD, Chumin EJ, Christian BT, et al. Differential dopamine function in fibromyalgia. Brain Imaging Behav. 2016;10(3):829-39. http://dx.doi.org/ 10.1007/s11682-015-9459-4

7. Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest. 2012;42(2):203-12. http://dx.doi.org/10.1111/j.1365-2362.2011.02575.x

8. Meeus M, Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol. 2007;26(4):465-73. http://dx.doi.org/10.1007/s10067-006-0433-9

9. Dell’Osso L, Carmassi C, Consoli G, Conversano C, Ramacciotti CE, Musetti L, et al. Lifetime post-traumatic stress symptoms are related to the health-related quality of life and severity of pain/fatigue in patients with fibromyalgia. Clin Exp Rheumatol. 2011;29(6 Suppl 69):S73-8. Disponible en : https://www.clinexprheumatol.org/abstract.asp?a=4749

10. Yavne Y, Amital D, Watad A, Tiosano S, Amital H. A systematic review of precipitating physical and psychological traumatic events in the development of fibromyalgia. Semin Arthritis Rheum. 2018;48(1):121-33. http://dx.doi.org/10.1016/j.semarthrit.2017.12.011

11. World Health Organization. Timeline: WHO’s COVID-19 response. 2019. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline

12. Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020;277:55-64. http://dx.doi.org/10.1016/j.jad.2020.08.001

13. Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):779-88. http://dx.doi.org/10.1016/j.dsx.2020.05.035

14. Puntillo F, Giglio M, Brienza N, Viswanath O, Urits I, Kaye AD, et al. Impact of COVID-19 pandemic on chronic pain management: Looking for the best way to deliver care. Best Pract Res Clin Anaesthesiol.2020;34(3):529-37. http://dx.doi.org/10.1016/j.bpa.2020.07.001

15. Hruschak V, Flowers KM, Azizoddin DR, Jamison RN, Edwards RR, Schreiber KL. Cross-sectional study of psychosocial and pain-related variables among patients with chronic pain during a time of social distancing imposed by the coronavirus disease 2019 pandemic. Pain. 2021;162(2):619-29. http://dx.doi.org/10.1097/j.pain.0000000000002128

16. Amital M, Ben-Shabat N, Amital H, Buskila D, Cohen AD, Amital D. COVID-19 associated hospitalization in 571 patients with fibromyalgia—A population-based study. Feng YM, editor. PLOS ONE. 2021;16(12):e0261772. http://dx.doi.org/10.1371/journal.pone.0261772

17. Salaffi F, Giorgi V, Sirotti S, Bongiovanni S, Farah S, Bazzichi L, et al. The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clin Exp Rheumatol. 2021;39(3):72-7. http://dx.doi.org/10.55563/clinexprheumatol/dnxtch

18. Fialho MFP, Brum ES, Oliveira SM. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Inflammopharmacology. 2023;31(2):633-51. http://dx.doi.org/10.1007/s10787-023-01160-w

19. Zale EL, Ditre JW. Pain-related fear, disability, and the fear-avoidance model of chronic pain. Curr Opin Psychol. 2015;5:24-30. http://dx.doi.org/10.1016/j.copsyc.2015.03.014

20. Cankurtaran D, Tezel N, Ercan B, Yildiz SY, Akyuz EU. The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study. Adv Rheumatol. 2021;61(1):41. http://dx.doi.org/10.1186/s42358-021-00200-9

21. Martínez-Líbano J, Torres-Vallejos J, Simkin H, Oyanedel Sepúlveda JC, Silva Fuentes A, Yeomans Cabrera MM. Escala de Miedo al Covid-19 en Estudiantes Universitarios Chilenos: Propiedades psicométricas e invarianza de medida. Rev Evaluar. 2023;22(3):48-65. https://doi.org/10.35670/1667-4545.v22.n3.39987

22. McCormack HM, De L. Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18(4):1007-19. http://dx.doi.org/10.1017/s0033291700009934

23. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17(1):45-56. http://dx.doi.org/10.1016/0304-3959(83)90126-4

24. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs.2005;14(7):798-804. http://dx.doi.org/10.1111/j.1365-2702.2005.01121.x

25. García Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S. Validación de la versión española de la escala de la catastrofización ante el dolor (Pain Catastrophizing Scale) en la fibromialgia. Med Clínica. 2008;131(13):487-92. http://dx.doi.org/10.1157/13127277

26. Gómez-Pérez L, López-Martínez AE, Ruiz-Párraga GT. Psychometric Properties of the Spanish Version of the Tampa Scale for Kinesiophobia (TSK). J Pain.2011;12(4):425-35. http://dx.doi.org/10.1016/j.jpain.2010.08.004

27. Esteve Vives JJ, Batlle Gualda E. Evaluación de pacientes con fibromialgia. Estudio comparativo de 4 versiones españolas del Fibromyalgia Impact Questionnaire (FIQ). Reumatol Clínica. 2006;2(6):283-8. Disponible en: https://www.reumatologiaclinica.org/es-pdf-S1699258X06730625

28. Rivera J, González T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. 2004;22(5):554-60.

29. Ley 21.096, de 5 junio 2018, Consagra el derecho a protección de los datos personales. 16 junio de 2018 ultima verisón [Consultada el 15 de junio de 2024] (Chile). Disponible en: https://www.bcn.cl/leychile/navegar?idNorma=1119730&tipoVersion=0

30. Ley 21.584, de 2 abril 2012, Consagra el derecho a protección de los datos personales. 28 mayo de 2024 última versión [Consultada el 15 de junio de 2024] (Chile). Disponible en: https://www.bcn.cl/leychile/navegar?idNorma=1039348

31. Yoshida T, Koyama T, Ishimaru T, Minoura A, Mutoh M, Tabuchi T. Fear of COVID-19 Among Japanese Workers and Exacerbation of Chronic Pain: A Nationwide Cross-Sectional Study. J Occup Environ Med. 2023;65(3):e134-40. http://dx.doi.org/10.1097/JOM.0000000000002772

32. Gaëtan Mertens G, Gerritse L, Duijndam S, Salemink E, Engelhardb IM. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020. J Anxiety Disord. 2020; 74:102258. http://dx.doi.org/10.1016/j.janxdis.2020.102258

33. Mertens G, Engelhard IM, Novacek DM, McNally RJ. Managing Fear During Pandemics: Risks and Opportunities. Perspect Psychol Sci. 2023;17456916231178720. http://dx.doi.org/10.1177/17456916231178720

34. Bartley EJ, Robinson ME, Staud R. Pain and Fatigue Variability Patterns Distinguish Subgroups of Fibromyalgia Patients. J Pain. 2018;19(4):372-381. http://dx.doi.org/10.1016/j.jpain.2017.11.014.

35. Mertens G, Gerritsen L, Duijndam S, Salemink E, Engelhard IM. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020. J Anxiety Disord. 2020;74(102258): 102258. http://dx.doi.org/10.1016/j.janxdis.2020.102258

Downloads

Published

2024-07-19

Issue

Section

Short communications

How to Cite

1.
Atenas-Nuñez E, Muñoz -Yánez MJ, Lizama-Lefno A, Roco-Videla Ángel, Caviedes-Olmos M. Prediction of Fear of COVID-19 in Women with Fibromyalgia: A Study of Psychosocial Factors Associated with Pain. Salud, Ciencia y Tecnología [Internet]. 2024 Jul. 19 [cited 2024 Nov. 13];4:1179. Available from: https://sct.ageditor.ar/index.php/sct/article/view/684